| CAMURUS AB |
| Schweden |
| Gesundheit |
| SE0007692850 / A2ABG7 |
| 7CA (Frankfurt) |
| FRA:7CA, ETR:7CA, 7CA:GR |
| - |
| https://www.camurus.com/ |
|
Camurus AB (publ) is a Swedish science-led biopharmaceutical company founded in 1991 and headquartered in Lund, specializing in the research, development, and commercialization of innovative, long-acting medicines for severe and chronic diseases. The..
>Volltext.. |
| 2616.2 Mio. EUR |
| 2286.61 Mio. EUR |
| 209.91 Mio. EUR |
| 84.24 Mio. EUR |
| 68.16 Mio. EUR |
| 1.15 EUR |
| 9.82 Mio. EUR |
| 345.25 Mio. EUR |
| 80.55 Mio. EUR |
| 10.15 |
| 28.54% |
| 81.95% |
| - |
| - |
| - |
| - |
| CAMURUS |
| 08.04.26 |
|